Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Design Characteristics and Risk of Bias of Pivotal Trials Supporting Approval of Hematological Drugs By FDA, 2008-2022: Cross Sectional Analysis

Sara Khan, Aruba Sohail, Maryum Hassan, Janta Ukrani, Areej Fatima, Muhammad Farooq, Kapisthalam S. Kumar

Blood (2023) 142 (Supplement 1): 3695.

https://doi.org/10.1182/blood-2023-183089

Published: 2023

Journal Articles

Unveiling Gender Disparities: Female Authorship in Pivotal Trials for US Food and Drug Administration (FDA)-Approved Novel Chimeric Antigen Receptor T-Cell Therapies

Muhammad Farooq, Aruba Sohail, Sara Khan, Janta Ukrani, Ibrahim Zahid, Maryum Hassan, Michael V. Jaglal

Blood (2023) 142 (Supplement 1): 7217.

https://doi.org/10.1182/blood-2023-181334

Published: 2023

Journal Articles

A 10 Year Analysis of Gender Distribution in National Institutes of Health Funding for Non-Malignant Hematology

Sara Khan, Faraz Eshaghi, Aruba Sohail, Kainat Khan, Taha Huda, Evan Lindbergh, Kapisthalam S. Kumar

Blood (2023) 142 (Supplement 1): 5113.

https://doi.org/10.1182/blood-2023-180317

Published: 2023

Journal Articles

Evaluation of Representation of Women As Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Hematological Drugs

Muhammad Zain Farooq, Aruba Sohail, Areej Fatima, Areesha Jawed, Michael Jaglal

Blood (2022) 140 (Supplement 1): 10775–10776.

https://doi.org/10.1182/blood-2022-168238

Published: 2022